Literature DB >> 2884260

Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.

P Kurki, M Lotz, K Ogata, E M Tan.   

Abstract

Proliferating cell nuclear antigen (PCNA), also called cyclin, is an intranuclear polypeptide whose synthesis reaches its maximum during the S-phase of the cell cycle. PCNA is expressed in several kinds of proliferating cells, one of which is the mitogen-stimulated human peripheral blood lymphocyte. PCNA expression increases from the late G1 phase through the S-phase of the cell cycle. This study is focused on the regulation of PCNA expression during the G1 phase of human T lymphocytes and on the relationship between PCNA expression and the rate of T cell proliferation. Special use is made of human autoantibodies to PCNA and the development of flow cytometry to label this intranuclear polypeptide. Unstimulated purified human peripheral blood T cells were PCNA negative. T cells treated with monoclonal antibody (64.1) to the CD3 complex expressed receptors for IL 2 but did not express PCNA until exogenous IL 2 was added to the culture. PCNA expression as well as the entry of the cells into S-phase could be inhibited by IL 2 receptor antibodies. Transferrin receptors were expressed only in T cells that were stimulated with both 64.1 and exogenous IL 2. Transferrin receptors were detectable before the cells expressed PCNA. Thus, the onset of PCNA expression is a phase in cell proliferation that follows transferrin receptor expression but preceded DNA synthesis. Drugs like dexamethasone and cyclosporin, which affect the early part of G1, inhibited PCNA expression; whereas cytarabine (ara-C) and hydroxyurea, which affect the S-phase and prevent DNA synthesis, did not block PCNA expression. There was a close correlation between the number of PCNA-positive cells and the number of S-phase cells in unperturbed T cell cultures. The highest level of PCNA expression was seen in cells that were in the first cycle after stimulation. The results show that PCNA expression is regulated by a signal after IL 2 binding and that PCNA labeling is a precise indicator for human T cells that are committed to DNA synthesis. Comparing these results with previous observations on the expression of some other activation-associated antigens, we suggest that the onset of PCNA expression represents a discrete step in T cell activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Preferential expansion and survival of B lymphocytes based on VH framework 1 and framework 3 expression: "positive" selection in appendix of normal and VH-mutant rabbits.

Authors:  R Pospisil; G O Young-Cooper; R G Mage
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

2.  Induction of the autoantigen proliferating cell nuclear antigen in T lymphocytes by a mycobacterial antigen.

Authors:  H M Haftel; Y Chang; R Hinderer; S M Hanash; J Holoshitz
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

3.  Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin.

Authors:  B A Wilson; L R Aminova; V G Ponferrada; M Ho
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle.

Authors:  B J Shenker; S Datar
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

5.  Detection of proliferating cell nuclear antigens and interleukin-2 beta receptor molecules on mitogen- and antigen-stimulated lymphocytes.

Authors:  J Hesketh; D Dobbelaere; J F Griffin; G Buchan
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

6.  Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults.

Authors:  S Katsuda; M D Coltrera; R Ross; A M Gown
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

7.  PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumors.

Authors:  D R Keim; N Hailat; R Kuick; C P Reynolds; G M Brodeur; R C Seeger; S M Hanash
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

8.  Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.

Authors:  Carsten Berges; Heinrich Haberstock; Dominik Fuchs; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel; Cord Naujokat
Journal:  Immunology       Date:  2008-01-23       Impact factor: 7.397

9.  The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production.

Authors:  María Rosa López-Huertas; Elena Mateos; María Sánchez Del Cojo; Francisco Gómez-Esquer; Gema Díaz-Gil; Sara Rodríguez-Mora; Juan Antonio López; Enrique Calvo; Guillermo López-Campos; José Alcamí; Mayte Coiras
Journal:  J Biol Chem       Date:  2013-01-30       Impact factor: 5.157

10.  Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.

Authors:  A E Dawson; J A Norton; D S Weinberg
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.